Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 4Gastrointestinal 3Thoracic 2Other hematologic neoplasm 2Lymphoid 2Genitourinary 2Tumor-Agnostic 1Other 1Myeloid 1Head & Neck 1Endocrine 1

Conditions

Lung Neoplasms 2Stomach Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Emergence Delirium 1Delirium 1Colorectal Neoplasms 1Cachexia 1Biliary Tract Neoplasms 1

Interventions

Carboplatin 510Cisplatin 410Pemetrexed 400Radiotherapy 285Docetaxel 244Paclitaxel 227pembrolizumab 226Gemcitabine 198Drug Therapy 191Bevacizumab 190Erlotinib Hydrochloride 189Radiosurgery 177Nivolumab 168Etoposide 155durvalumab 154osimertinib 126atezolizumab 109Gefitinib 96Blood Specimen Collection 93Magnetic Resonance Spectroscopy 91Vinorelbine 90anlotinib 88Surgical Procedures, Operative 85Ipilimumab 62Immunotherapy 62Surveys and Questionnaires 60sintilimab 59Specimen Handling 59tislelizumab 58Irinotecan 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Ibuprofen × Thoracic × Clear all
NCT05834569 2025-09-05

Impact of Maxigesic on Delirium After Minimally Invasive Lung Surgery in Elderly Patients

Korea University Guro Hospital

Phase 4 Terminated
25 enrolled
Thoracic

Emergence Delirium, Delirium, Lung Neoplasms

NCT04907864 2021-06-01

MIRACLE

Kyunghee University Medical Center

Phase 2 Unknown
112 enrolled
GastrointestinalThoracic

Biliary Tract Neoplasms, Cachexia, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡